Dr Kai Kretzschmar (Image: Angela Riedel / Universität Würzburg)
Dr Kai Kretzschmar (Image: Angela Riedel / Universität Würzburg) - Cancer researcher Dr Kai Kretzschmar wants to find out why oral cancers are so heterogeneous. He is receiving funding of 1.77 million euros for this project. Oral squamous cell carcinoma is the most common malignant tumour type in the oral cavity. It differs greatly from patient to patient, for example, in terms of the development of metastases or the response to therapy. Why is this cancer type so heterogeneous? Dr Kai Kretzschmar wants to find out in his new project OralNiche . The junior group leader at the Mildred Scheel Early Career Centre for Cancer Research Würzburg is receiving top-class funding for this: the European Research Council (ERC) has awarded him a Starting Grant of 1.77 million euros. This award is given to outstanding young researchers in a Europe-wide competition.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
